Common Contracts
6 similar Common Stock Purchase Agreement contracts by Cytokinetics Inc, Amgen Inc
CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 6th, 2020 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of July 14, 2020 (the “Closing Date”) by and between Cytokinetics, Incorporated, a Delaware corporation (the “Company”), and [•], with a business address located at [•] (the “Investor”).
CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 6th, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of February 1, 2017 (the “Execution Date”) by and between Cytokinetics, Incorporated, a Delaware corporation (the “Company”), and RPI Finance Trust, a Delaware statutory trust (the “Investor”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • December 23rd, 2014 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of December 22nd, 2014 (the “Execution Date”) by and between Cytokinetics, Incorporated, a Delaware corporation (the “Company”), and Astellas Pharma Inc. (the “Investor”). All terms not defined herein shall have the meaning set forth for such terms in the Amended and Restated License and Collaboration Agreement, dated as of December 22nd, 2014 by and between the Company and the Investor, as amended on the date hereof (the “Collaboration Agreement”).
CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 12th, 2013 • Cytokinetics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of June 11, 2013 (the “Execution Date”) by and between Cytokinetics, Incorporated, a Delaware corporation (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”). All terms not defined herein shall have the meaning set forth for such terms in the Collaboration and Option Agreement, dated as of December 29, 2006 by and between the Company and the Investor, as amended on the date hereof (the “Collaboration Agreement”).
CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • January 8th, 2007 • Amgen Inc • Biological products, (no disgnostic substances) • California
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of December 29, 2006 (the “Execution Date”) by and between Cytokinetics, Incorporated, a Delaware corporation (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”). All terms not defined herein shall have the meaning set forth for such terms in the Collaboration and Option Agreement, dated as of December 29, 2006 by and between the Company and the Investor (the “Collaboration Agreement”).
CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • January 3rd, 2007 • Cytokinetics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of December 29, 2006 (the “Execution Date”) by and between Cytokinetics, Incorporated, a Delaware corporation (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”). All terms not defined herein shall have the meaning set forth for such terms in the Collaboration and Option Agreement, dated as of December 29, 2006 by and between the Company and the Investor (the “Collaboration Agreement”).
